NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Prevalence and Characterisation of Asthma Patients According to Disease Severity in Portugal
Prevalence and Characterisation of Asthma Patients According to Disease Severity in Portugal

NCT05169619

CompletedN/A

Sponsor: AstraZeneca

Conditions: Asthma

Countries: Portugal

This study aims to determine the prevalence of Asthma, Difficult-to-Treat and Severe Asthma in Portugal, and characterize patients to better understand their disease characteristics, treatment profile and health care resource use to improve clinical management of the disease.

Eligibility overview

Sex: ALL

Age: 18 Years to

Healthy volunteers: Yes

Study type: OBSERVATIONAL

Eligibility criteria
Inclusion Criteria:

* Adults =\>18 years old registered in Portuguese National Health service patients' database of primary care units.
* Give voluntary signed informed consent,
* Ability to understand ans answer questionnaires.

Exclusion Criteria:

* Participants that have a physical condition that could interfere with the study assessments or prevent the participant from adequately participating in the study (e.g. mobility problems, not able to perform spirometry,…)
Locations (37)
  • Alpendorada, Portugal, Portugal
  • Vila Cova Da Lixa, Portugal, Portugal
  • Aradas, Portugal
  • Arazede, Portugal
  • Braga, Portugal
  • Cascais, Portugal
  • Coimbra, Portugal
  • Evora, Portugal
  • Evora, Portugal
  • Fafe, Portugal
  • Leiria, Portugal
  • Lisbon, Portugal
  • Lisbon, Portugal
  • Lisbon, Portugal
  • Mafra, Portugal
  • Montenegro, Portugal
  • Oeiras, Portugal
  • Ovar, Portugal
  • Pinhal Novo, Portugal
  • Ponte, Portugal
  • Porto, Portugal
  • Porto, Portugal
  • Porto, Portugal
  • Porto, Portugal
  • Queluz, Portugal
  • Quinta Do Conde, Portugal
  • Ribeira de Pena, Portugal
  • Rio de Mouro, Portugal
  • Tavira, Portugal
  • Tomar, Portugal
  • + 7 more on CT.gov